NewAmsterdam Pharma Co N.V. Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NewAmsterdam Pharma Co N.V. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2025.
  • NewAmsterdam Pharma Co N.V. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $246K, a 50.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

NewAmsterdam Pharma Co N.V. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $246K -$247K -50.1% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $308K -$246K -44.4% Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $369K +$331K +871% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $431K +$376K +684% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 $493K Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $554K Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $38K Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $55K -$65K -54.2% Dec 31, 2023 10-K 2025-02-26
Q4 2022 $120K Dec 31, 2022 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.